Potential application of probiotics in attenuating the link between COVID-19 and mucormycosis
COVID-19 has caused a significant amount of mortality and morbidity worldwide. It has paved the way for a plethora of complications including increase in the incidence of some previously rare diseases. Mucormycosis is one such opportunistic infection that has gained prominence in certain developing...
Main Authors: | Rohan Kumar Polamarasetty, P Divya |
---|---|
Format: | Article |
Language: | English |
Published: |
Jaypee Brothers Medical Publisher
2022-01-01
|
Series: | Indian Journal of Respiratory Care |
Subjects: | |
Online Access: | http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=2;spage=95;epage=100;aulast=Polamarasetty |
Similar Items
-
Mucormycosis: An Epidemic Complicating the COVID-19 Pandemic
by: Shalaka Khade, et al.
Published: (2023-05-01) -
Post Covid-19 Mandibular Mucormycosis: A Rare and Deviant Site of Presentation
by: Ravishankar C, et al.
Published: (2023-07-01) -
Mucormycosis and diabetes in the times of COVID-19: A Mumbai-based observational study
by: Anupa R A. Hinduja, et al.
Published: (2022-01-01) -
Simplified screening and referral protocol for sinonasal mucormycosis in post COVID-19 patients
by: Jitendra Singh, et al.
Published: (2023-04-01) -
Mucormycosis in COVID-19
by: Vasantha Kamath, et al.
Published: (2021-01-01)